MedNova provides end-to-end regulatory affairs services — from product registration and NAFDAC submissions through import permits and lifecycle management — to help companies reach and stay in African markets.
Not a list of departments — the actual phases a product moves through, from first dossier to ongoing renewal.
Technology enabled — we use proprietary digital tools to support regulatory workflows, with every output reviewed by our regulatory team.
Registering pharmaceutical, medical device, nutraceutical, and food supplement products with NAFDAC and other relevant African regulatory authorities — matched to the correct product category and pathway from the start.
Compiling technical, quality, and safety documentation into a submission-ready dossier, formatted to the specific requirements of the receiving authority rather than a generic template.
Managing the filing process directly with NAFDAC — application forms, fees, sample submission, and facility documentation handled as one coordinated package.
Mapping the fastest realistic pathway to approval for a given product and category, so submission sequencing is planned rather than discovered mid-process.
Securing import permits for products entering Nigeria — coordinated against the shipment timeline so cleared product doesn't sit waiting on paperwork.
Carrying a submission through to a granted Marketing Authorization (MA), including responding to regulatory queries raised during technical review.
Registering manufacturing and distribution facilities where required, so facility status doesn't become the bottleneck holding up a product approval.
Reviewing and clearing product labeling and promotional material against current regulatory requirements ahead of market launch.
Tracking registration expiry dates and managing renewal filings ahead of deadline, so continued market authorization doesn't lapse.
Filing variations for formulation, packaging, manufacturing site, or labeling changes — keeping the registration current as the product itself evolves.
Managing Marketing Authorization Holder (MAH) transfers when ownership, distribution rights, or local representation changes.
Renewing import permits in step with shipment schedules, so recurring import needs are handled proactively rather than case by case.
Monitoring NAFDAC and regional guideline changes that affect a client's existing registrations, and flagging what action they require.
Keeping registration files and facility documentation in a state ready for regulatory inspection at any point — not assembled after a notice arrives.
Preparing timely, technically sound responses to regulatory queries raised on existing submissions or registrations.
Reviewing a client's existing registration portfolio for expiry risk, gaps, and outstanding variations before they become compliance issues.
Hands-on familiarity with how NAFDAC's submission process and documentation standards actually work in practice — not just what the guideline documents say.
Dossiers built right the first time and query responses turned around quickly, so timelines aren't lost to avoidable back-and-forth.
Registration is the start of the relationship, not the end — one partner through renewals, variations, and, when needed, clinical and pharmacovigilance support.
Registration experience spanning pharmaceuticals, medical devices, nutraceuticals, and food supplements — built to flex from a single SKU to a multi-country program.
We'd rather be excellent in a few categories than merely present in many — so we've started with the categories where our documentation and review experience is deepest.
MedNova Regulatory Affairs is led by a team with hands-on registration and submission experience, applied directly to bringing products to market in Nigeria and across Africa — local regulatory knowledge and documentation discipline, held together by one accountable team.
Answer six questions to get an instant readiness score for registering your product with NAFDAC — a real assessment tool, not a demo.
Whether you're scoping a first submission or managing a growing portfolio — we'd like to hear what you're working on.